Biomerica, Inc.
BMRA
$2.71
-$0.08-2.87%
NASDAQ
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.38M | 749.00K | 1.12M | 1.64M | 1.81M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.38M | 749.00K | 1.12M | 1.64M | 1.81M |
| Cost of Revenue | 956.00K | 993.00K | 1.10M | 1.20M | 1.52M |
| Gross Profit | 424.00K | -244.00K | 19.00K | 437.00K | 289.00K |
| SG&A Expenses | 1.33M | 1.07M | 1.01M | 1.17M | 1.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.50M | 2.31M | 2.33M | 2.63M | 3.18M |
| Operating Income | -1.12M | -1.56M | -1.21M | -993.00K | -1.37M |
| Income Before Tax | 5.00K | -1.54M | -1.17M | -953.00K | -1.31M |
| Income Tax Expenses | 3.00K | 5.00K | -4.00K | -3.00K | 4.00K |
| Earnings from Continuing Operations | 2.00K | -1.54M | -1.16M | -950.00K | -1.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.00K | -1.54M | -1.16M | -950.00K | -1.32M |
| EBIT | -1.12M | -1.56M | -1.21M | -993.00K | -1.37M |
| EBITDA | -1.10M | -1.54M | -1.19M | -971.00K | -1.35M |
| EPS Basic | 0.00 | -0.70 | -0.48 | -0.44 | -0.63 |
| Normalized Basic EPS | 0.00 | -0.44 | -0.30 | -0.28 | -0.39 |
| EPS Diluted | 0.00 | -0.73 | -0.48 | -0.48 | -0.63 |
| Normalized Diluted EPS | 0.00 | -0.44 | -0.30 | -0.28 | -0.39 |
| Average Basic Shares Outstanding | 2.64M | 2.21M | 2.40M | 2.14M | 2.10M |
| Average Diluted Shares Outstanding | 2.64M | 2.21M | 2.40M | 2.14M | 2.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |